Life Sciences Reporter, Boston Business Journal
“Using immense amounts of data, AI not only has clinical applications — as in diagnosing patients — but can also be harnessed for behind-the-scenes uses, such as making the development of new drugs more efficient.”
The Boston Business Journal article highlights the rising influence of artificial intelligence in these fields, particularly focusing on FDNA’s Face2Gene technology. Face2Gene uses AI algorithms to examine facial features and diagnose genetic disorders, significantly improving the speed and accuracy of diagnoses. This clinical decision support tool exemplifies how AI is transforming personalized medicine by enabling early detection and tailored treatment plans. The article emphasizes the broader impact of the role of AI on healthcare, enhancing patient care, and streamlining clinical processes.
